Literature DB >> 7106176

The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.

B Resul, T Lewander, B Ringdahl, T Zetterström, R Dahlbom.   

Abstract

Some of the central and peripheral effects of oxotremorine (OT) and its azetidine analogue, N-[4-azetidinyl)-2-butynyl]-2-pyrrolidone (BM 120), were compared in mice and rats. BM 120 was found to be about twice as potent as OT and to have a somewhat longer duration of action. All its effects were antagonized by pretreatment with atropine sulphate. BM 120 acted as powerful muscarinic agonist on the isolated guinea pig ileum.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7106176     DOI: 10.1016/0014-2999(82)90056-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.

Authors:  C Engström; A Undén; H Ladinsky; S Consolo; T Bartfai
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Differential response to cholinergic stimulation in psychogenitically selected rat lines.

Authors:  J R Martin; P Driscoll; C Gentsch
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice.

Authors:  P Worms; K Biziere
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.